Literature DB >> 1677327

Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.

B Kreymann1, M A Ghatei, J Domin, S Kanse, S R Bloom.   

Abstract

Glucagon-like peptide-(17-36) amide [GLP-1-(7-36) amide] and peptide tyrosine tyrosine (PYY) are both products of the enteroglucagon cell. To examine the changes occurring during development, we analyzed by RIA the pancreatic concentrations of these two peptides in fetal and neonatal rats. The levels obtained were compared with those of the classical islet hormones, insulin, somatostatin, and glucagon. The total hormone content of the pancreas increased with age for insulin, glucagon, and somatostatin. The amounts of GLP-1-(7-36) amide immunoreactivity (IR) and PYY, however, remained approximately constant in the 3-, 8-, and 30-day-old and adult pancreas. GLP-1-(7-36) amide IR showed only a single peak by gel chromatography, but further analysis by anion exchange chromatography showed that during the fetal period (-18 days) and 3 days postpartum GLP-1-(7-36) amide was the main product, whereas 30 days postpartum and in adult pancreas mainly GLP-1 and an intermediate form were found. Similar analyses of gut extracts revealed that only GLP-1-(7-36) amide is produced during intestinal development. The gut content of GLP-1-(7-36) amide IR and PYY IR increased approximately 100 times between the fetus and the 30-day-old rat. This study reveals a complex and specific regulation of posttranslational processing during maturation for these two peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677327     DOI: 10.1210/endo-129-2-1001

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  GLP-1 and IGF-I levels are elevated in late infancy in low birth weight infants, independently of GLP-1 receptor polymorphisms and neonatal nutrition.

Authors:  M Díaz; C García-Beltran; A López-Bermejo; F de Zegher; L Ibáñez
Journal:  Int J Obes (Lond)       Date:  2017-11-01       Impact factor: 5.095

2.  Stimulation of insulin and somatostatin release by two meglitinide analogs.

Authors:  V Leclercq-Meyer; L Ladrière; J Fuhlendorff; W J Malaisse
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

3.  A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.

Authors:  P Marchetti; R Lupi; M Bugliani; C L Kirkpatrick; G Sebastiani; F A Grieco; S Del Guerra; V D'Aleo; S Piro; L Marselli; U Boggi; F Filipponi; L Tinti; L Salvini; C B Wollheim; F Purrello; F Dotta
Journal:  Diabetologia       Date:  2012-09-11       Impact factor: 10.122

Review 4.  Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function.

Authors:  Ellen M Davis; Darleen A Sandoval
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 8.915

5.  Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (α-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells.

Authors:  Salvatore Piro; Loriana G Mascali; Francesca Urbano; Agnese Filippello; Roberta Malaguarnera; Salvatore Calanna; Agata M Rabuazzo; Francesco Purrello
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.